MoneyWorks4Me

Cadila Healthcare informs about press release

18 Jul 2018 Evaluate

Cadila Healthcare has informed about press release titled, ' Zydus receives four consecutive ANDA approvals from the USFDA'.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1103.00 -5.80 (-0.52%)
21-Aug-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1890.40
Dr. Reddys Labs. 1176.90
Cipla 1425.00
Lupin 2197.80
Zydus Lifesciences 1103.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: